France Veterinary Anthrax Vaccines Market Insight
France Veterinary Anthrax Vaccines market size is growing at a 5.8% CAGR, driven by increasing livestock vaccination programs, rising prevalence of bacterial animal diseases, and expanding commercial farming operations.
France Veterinary Anthrax Vaccines Market Insights Forecasts to 2035
- The France Veterinary Anthrax Vaccines Market Size Was Estimated at USD 34.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 5.8% from 2025 to 2035
- The France Veterinary Anthrax Vaccines Market Size is Expected to Reach USD 61.13 Million by 2035
Notable Insights for France Veterinary Anthrax Vaccines Market
- The live attenuated vaccines segment dominates the France veterinary anthrax vaccines market and generated approximately USD 19 million in revenue during 2025. Strong livestock disease prevention effectiveness continues supporting segment growth.
- The government-supported vaccination segment is expected to witness strong growth during the forecast period with an estimated CAGR of 6.5%, supported by increasing biosecurity initiatives and livestock disease monitoring programs.
- Approximately 55% of total market revenue in France is generated by live attenuated anthrax vaccines, ensuring stronger livestock immunity levels.
- Nearly 60% of market demand comes from cattle and sheep farming operations, supporting large-scale preventive vaccination programs.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Veterinary Anthrax Vaccines market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Veterinary Anthrax Vaccines Market
- Ceva Sante Animale
- Zoetis
- Boehringer Ingelheim Animal Health
- Merck Animal Health
- Elanco Animal Health
- HIPRA
- Virbac
- Indian Immunologicals
- Bioveta
- Vetoquinol
- Others
Recent Developments:
- In April 2026, Ceva Sante Animale expanded its livestock vaccine portfolio supporting preventive bacterial disease management across European farming operations.
- In January 2026, Zoetis strengthened its veterinary immunization technologies designed for improved livestock disease prevention and herd health management.
- In October 2025, Boehringer Ingelheim Animal Health enhanced its animal vaccine production capabilities targeting infectious livestock diseases.
Market Segmentation:
France Veterinary Anthrax Vaccines Market, By Vaccine Type
- Live Attenuated Vaccines
- Inactivated Vaccines
France Veterinary Anthrax Vaccines Market, By Animal Type
- Cattle
- Sheep & Goats
- Horses
- Others
France Veterinary Anthrax Vaccines Market, By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Government Vaccination Programs
- Others
Expert Views:
The France veterinary anthrax vaccines market will expand steadily due to livestock disease prevention initiatives, veterinary healthcare awareness, and animal biosecurity investments. Expanded vaccination programs, veterinary biologics innovation, commercial livestock farming growth, and zoonotic disease prevention emphasis will drive future expansion.